The Pfizer Vaccines US Medical Affairs Team will be offering an educational webinar series titled Translating mRNA which is focused on providing education on COVID-19 and vaccination. The webinar series is designed to communicate scientific information including recent study results to support healthcare providers’ knowledge regarding Pfizer and BioNTech’s COVID-19 Vaccines including the COVID-19 vaccine, Bivalent (Original and Omicron BA.4/BA.5).
The webinar series will include a live question-and-answer session with Pfizer medical experts.
The following Translating mRNA sessions on the topics below will be hosted:
1. Select Bivalent COVID-19 Vaccine Information Presented at Recent FDA Advisory Committee Meeting
Monday, 13 February 2023: 12:00 pm – 1:00 pm EST or
Tuesday, 14 February 2023: 5:00 pm – 6:00 pm EST or
Wednesday, 15 February 2023: 3:00 pm – 4:00 pm EST
Speaker: Rajeev M Nepal, PhD
Medical Director, Pfizer mRNA Vaccines, Medical and Scientific Affairs, USA
2. COVID-19 Vaccination: Considerations for Pediatric Patients
Monday, 27 February 2023: 12:00 pm – 1:00 pm EST or
Tuesday, 28 February 2023: 5:00 pm – 6:00 pm EST or
Wednesday, 01 March 2023: 3:00 pm – 4:00 pm EST
Speaker: Maria D. McColgan, MD, MSEd
Medical Director, Pfizer mRNA Vaccines, Medical and Scientific Affairs, USA
Target Audience: All healthcare professionals including but not limited to physicians, nurse practitioners, pharmacists, and physician assistants.
*Continuing medical education credit is NOT associated with this event. *
For more information, please see the full Prescribing Information and EUA Fact Sheets for Vaccination Providers here.